108 related articles for article (PubMed ID: 13679031)
1. Hmga2 promoter analysis in transgenic mice.
Schiltz JF; Rustighi A; Tessari MA; Liu J; Braghetta P; Sgarra R; Stebel M; Bressan GM; Altruda F; Giancotti V; Chada K; Manfioletti G
Biochem Biophys Res Commun; 2003 Oct; 309(4):718-23. PubMed ID: 13679031
[TBL] [Abstract][Full Text] [Related]
2. Human HMGA2 promoter is coregulated by a polymorphic dinucleotide (TC)-repeat.
Borrmann L; Seebeck B; Rogalla P; Bullerdiek J
Oncogene; 2003 Feb; 22(5):756-60. PubMed ID: 12569368
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2.
Tessari MA; Gostissa M; Altamura S; Sgarra R; Rustighi A; Salvagno C; Caretti G; Imbriano C; Mantovani R; Del Sal G; Giancotti V; Manfioletti G
Mol Cell Biol; 2003 Dec; 23(24):9104-16. PubMed ID: 14645522
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.
Lin HH; Xiong Y; Ho YS; Zhou B; Nguyen HV; Deng H; Lee R; Yen Y; Borok Z; Ann DK
Eur J Oral Sci; 2007 Feb; 115(1):30-9. PubMed ID: 17305714
[TBL] [Abstract][Full Text] [Related]
5. A crucial role of a high mobility group protein HMGA2 in cardiogenesis.
Monzen K; Ito Y; Naito AT; Kasai H; Hiroi Y; Hayashi D; Shiojima I; Yamazaki T; Miyazono K; Asashima M; Nagai R; Komuro I
Nat Cell Biol; 2008 May; 10(5):567-74. PubMed ID: 18425117
[TBL] [Abstract][Full Text] [Related]
6. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.
De Martino I; Visone R; Wierinckx A; Palmieri D; Ferraro A; Cappabianca P; Chiappetta G; Forzati F; Lombardi G; Colao A; Trouillas J; Fedele M; Fusco A
Cancer Res; 2009 Mar; 69(5):1844-50. PubMed ID: 19223528
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.
Ferguson M; Henry PA; Currie RA
Nucleic Acids Res; 2003 Jun; 31(12):3123-33. PubMed ID: 12799440
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-specific expression of the alpha 2(I) collagen promoter in transgenic mice: correlation with the distribution of TGF-beta 1.
D'Souza RN; Niederreither K; de Crombrugghe B
J Bone Miner Res; 1993 Sep; 8(9):1127-36. PubMed ID: 8237483
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice.
Metsäranta M; Garofalo S; Smith C; Niederreither K; de Crombrugghe B; Vuorio E
Dev Dyn; 1995 Oct; 204(2):202-10. PubMed ID: 8589444
[TBL] [Abstract][Full Text] [Related]
10. Molecular dissection of the architectural transcription factor HMGA2.
Noro B; Licheri B; Sgarra R; Rustighi A; Tessari MA; Chau KY; Ono SJ; Giancotti V; Manfioletti G
Biochemistry; 2003 Apr; 42(15):4569-77. PubMed ID: 12693954
[TBL] [Abstract][Full Text] [Related]
11. The specificity of the myelin basic protein gene promoter studied in transgenic mice.
Asipu A; Mellor AL; Blair GE
Biochem Biophys Res Commun; 2001 Nov; 288(4):809-18. PubMed ID: 11688980
[TBL] [Abstract][Full Text] [Related]
12. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.
Zaidi MR; Okada Y; Chada KK
Cancer Res; 2006 Aug; 66(15):7453-9. PubMed ID: 16885341
[TBL] [Abstract][Full Text] [Related]
13. HMGA2: A pituitary tumour subtype-specific oncogene?
Fedele M; Palmieri D; Fusco A
Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 is expressed in an allele-specific manner in human lipomas.
Ashar HR; Tkachenko A; Shah P; Chada K
Cancer Genet Cytogenet; 2003 Jun; 143(2):160-8. PubMed ID: 12781451
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.
Fedele M; Battista S; Kenyon L; Baldassarre G; Fidanza V; Klein-Szanto AJ; Parlow AF; Visone R; Pierantoni GM; Outwater E; Santoro M; Croce CM; Fusco A
Oncogene; 2002 May; 21(20):3190-8. PubMed ID: 12082634
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
[TBL] [Abstract][Full Text] [Related]
17. Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2.
Crombez KR; Vanoirbeek EM; Van de Ven WJ; Petit MM
Mol Cancer Res; 2005 Feb; 3(2):63-70. PubMed ID: 15755872
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma.
Rabban JT; Dal Cin P; Oliva E
Int J Gynecol Pathol; 2006 Oct; 25(4):403-7. PubMed ID: 16990720
[TBL] [Abstract][Full Text] [Related]
19. A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genes.
Rustighi A; Tessari MA; Vascotto F; Sgarra R; Giancotti V; Manfioletti G
Biochemistry; 2002 Jan; 41(4):1229-40. PubMed ID: 11802722
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the regulatory regions in the human desmoglein genes encoding the pemphigus foliaceous and pemphigus vulgaris antigens.
Adams MJ; Reichel MB; King IA; Marsden MD; Greenwood MD; Thirlwell H; Arnemann J; Buxton RS; Ali RR
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):165-74. PubMed ID: 9405290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]